Trond Viset
Overview
Explore the profile of Trond Viset including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
591
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kiviaho A, Eerola S, Kallio H, Andersen M, Hoikka M, Tiihonen A, et al.
Nat Commun
. 2024 Nov;
15(1):9949.
PMID: 39550375
Prostate cancer treatment resistance is a significant challenge facing the field. Genomic and transcriptomic profiling have partially elucidated the mechanisms through which cancer cells escape treatment, but their relation toward...
2.
Andersen M, Krossa S, Midtbust E, Pedersen C, Wess M, Hoiem T, et al.
Commun Biol
. 2024 Nov;
7(1):1462.
PMID: 39511287
Prostate tumor heterogeneity is a major obstacle when studying the biological mechanisms of molecular markers. Increased gene expression levels of secreted frizzled-related protein 4 (SFRP4) is a biomarker in aggressive...
3.
Thorkildsen J, Taksdal I, Bjerkehagen B, Haugland H, Johannesen T, Viset T, et al.
Acta Oncol
. 2019 Jan;
58(3):273-282.
PMID: 30632866
Background: Knowledge of chondrosarcoma (CS) of bone to date is based on institutional reports and registry publications with limits in reporting, detail and quality of data. Method: We have performed...
4.
Sogaard C, Blindheim A, Rost L, Petrovic V, Nepal A, Bachke S, et al.
Oncotarget
. 2018 Sep;
9(65):32448-32465.
PMID: 30197755
Low response rate and rapid development of resistance against commonly used chemotherapeutic regimes demand new multi-targeting anti-cancer strategies. In this study, we target the stress-related roles of the scaffold protein...
5.
Dybos S, Flatberg A, Halgunset J, Viset T, Rolfseng T, Kvam S, et al.
APMIS
. 2018 Aug;
126(9):722-731.
PMID: 30160020
Prostate cancer (PCa) is one of the most common types of cancer and the fifth leading cause of death among men worldwide. The tools for diagnosing PCa have limited value,...
6.
Sandsmark E, Hansen A, Selnaes K, Bertilsson H, Bofin A, Wright A, et al.
Oncotarget
. 2016 Dec;
8(6):9572-9586.
PMID: 28030815
Activation of the Canonical Wnt pathway (CWP) has been linked to advanced and metastatic prostate cancer, whereas the Wnt5a-induced non-canonical Wnt pathway (NCWP) has been associated with both good and...
7.
Panagopoulos I, Gorunova L, Viset T, Heim S
Oncol Rep
. 2016 Sep;
36(5):2455-2462.
PMID: 27633981
We present an angiofibroma of soft tissue with the karyotype 46,XY,t(4;5)(q24;q31),t(5;8;17)(p15;q13;q21)[8]/46,XY,t(1;14)(p31;q32)[2]/46,XY[3]. RNA‑sequencing showed that the t(4;5)(q24;q31) resulted in recombination of the genes TBCK on 4q24 and P4HA2 on 5q31.1 with...
8.
Hansen A, Sandsmark E, Rye M, Wright A, Bertilsson H, Richardsen E, et al.
Oncotarget
. 2016 Jun;
7(27):42071-42085.
PMID: 27276682
TMPRSS2-ERG has been proposed to be a prognostic marker for prostate cancer. The aim of this study was to identify changes in metabolism, genes and biochemical recurrence related to TMPRSS2-ERG...
9.
Slagsvold J, Viset T, Wibe A, Kaasa S, Widmark A, Lund J
Int J Radiat Oncol Biol Phys
. 2016 May;
95(4):1268-72.
PMID: 27130793
Purpose: To investigate long-term changes in the rectal mucosa after curative external beam radiation therapy in the treatment of prostate cancer. Methods And Materials: In the Scandinavian Prostate Cancer Group...
10.
Gederaas O, Sogaard C, Viset T, Bachke S, Bruheim P, Arum C, et al.
Transl Oncol
. 2014 Dec;
7(6):812-23.
PMID: 25500092
Non-muscle-invasive bladder cancers (NMIBCs) are tumors confined to the mucosa or the mucosa/submucosa. An important challenge in treatment of NMIBC is both high recurrence and high progression rates. Consequently, more...